Personalized Oncogenomics: Clinical Experience with Malignant Peritoneal Mesothelioma Using Whole Genome Sequencing

• Brandon S. Sheffield,

  Affiliation University of British Columbia, Department of Pathology and Laboratory Medicine, Vancouver, Canada

  ⨯
• Anna V. Tinker,

  Affiliation British Columbia Cancer Agency, Division of Medical Oncology, Vancouver Centre, Vancouver, Canada

  ⨯
• Yaoqing Shen,

  Affiliation Canada’s Michael Smith Genome Sciences Centre, British Columbia Cancer Agency, Vancouver, Canada

  ⨯
• Harry Hwang,

  Affiliation PhenoPath Laboratories, Seattle, Washington, United States of America

  ⨯
• Hector H. Li-Chang,

  Affiliation University of British Columbia, Department of Pathology and Laboratory Medicine, Vancouver, Canada

  ⨯
• Erin Pleasance,

  Affiliation Canada’s Michael Smith Genome Sciences Centre, British Columbia Cancer Agency, Vancouver, Canada

  ⨯
• Carolyn Ch’ng,

  Affiliation Canada’s Michael Smith Genome Sciences Centre, British Columbia Cancer Agency, Vancouver, Canada

  ⨯
• Amy Lum,

  Affiliation University of British Columbia, Department of Pathology and Laboratory Medicine, Vancouver, Canada

  ⨯
• Julie Lorette,

  Affiliation University of British Columbia, Department of Pathology and Laboratory Medicine, Vancouver, Canada

  ⨯
• Yarrow J. McConnell,

  Affiliation University of British Columbia, Department of Surgery, Surgical Oncology, Vancouver, Canada

  ⨯
• Sophie Sun,

  Affiliation British Columbia Cancer Agency, Division of Medical Oncology, Vancouver Centre, Vancouver, Canada

  ⨯
• Steven J. M. Jones,

  Affiliation Canada’s Michael Smith Genome Sciences Centre, British Columbia Cancer Agency, Vancouver, Canada

  ⨯
• Allen M. Gown,

  Affiliations University of British Columbia, Department of Pathology and Laboratory Medicine, Vancouver, Canada, PhenoPath Laboratories, Seattle, Washington, United States of America

  ⨯
• David G. Huntsman,

  Affiliation University of British Columbia, Department of Pathology and Laboratory Medicine, Vancouver, Canada

  ⨯
• David F. Schaeffer,

  Affiliation University of British Columbia, Department of Pathology and Laboratory Medicine, Vancouver, Canada

  ⨯
• Andrew Churg,

  Affiliation University of British Columbia, Department of Pathology and Laboratory Medicine, Vancouver, Canada

  ⨯
• Stephen Yip,

  Affiliation University of British Columbia, Department of Pathology and Laboratory Medicine, Vancouver, Canada

  ⨯
• Janessa Laskin ,

  * E-mail: jlaskin@bccancer.bc.ca (J. Laskin); mmarra@bcgsc.ca (MM)

  Affiliation British Columbia Cancer Agency, Division of Medical Oncology, Vancouver Centre, Vancouver, Canada

  ⨯
•  [ ... ],
• Marco A. Marra

  * E-mail: jlaskin@bccancer.bc.ca (J. Laskin); mmarra@bcgsc.ca (MM)

  Affiliation Canada’s Michael Smith Genome Sciences Centre, British Columbia Cancer Agency, Vancouver, Canada

  ⨯
• [ view all ]
• [ view less ]